“Charles River Laboratories International, Inc. (NYSE:CRL) is the world’s leading provider of research models and other services for preclinical research and drug development.

The annual five-day census of swans belonging to King Charles III has begun along the River Thames. The centuries-old tradition involves inspecting members of the mute swan species. One of ...

BOSTON (WHDH) - It was a race to the rescue on the Charles River on Sunday as officials say emergency crews pulled someone from the water. The incident occurred in the area of the Esplanade around ...

The Charles River Watershed Association urges municipalities to reduce stormwater runoff and for key entities to halt sewage releases into the river.

SUMMER IN THE CITY Take me to the river: The many ways to enjoy the Charles this summer Here are four sweet segments along the paved walking and cycling loop.

Shares of Charles River Laboratories International Inc. CRL slid 3.96% to $145.05 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index ...

The firm has three possible paths toward value creation at the drug development company.

Business: Charles River Laboratories is an early-stage contract research company. The company engages in laboratory animal medicine and science (research model technologies), and it has developed ...

Charles River Laboratories International, Inc. (NYSE: CRL) Q1 2025 Results Conference Call May 7, 2025 9:00 AM ET Company Participants Todd Spencer - Vice President, Investor Relations Jim Foster ...

Charles River Laboratories shares jumped 15% on Wednesday after the company raised its annual profit forecast due to improving demand for contract drug research services.